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Abst ract 
This article demonstrates the results of the comparative analysis of parameters of the structural 
and functional heart, blood vessels and liver remodeling in patients with essential hypertension 
combined with diabetes mellitus type 2 and obesity. It was established that irrespective 
of BMI the patients with essential hypertension and diabetes mellitus type 2 in comparison with 
hypertensive patients had different values of thickness of the intima-media in the carotid arteries 
(which were significantly higher), different pulse wave velocity in the great vessels, the size of the 
cavities and myocardial mass of the left ventricle, the integral index of diastolic filling E/e (integral 
ratio of maximum velocities of early diastolic filling according to spectral and tissue Doppler 
studies), the index of rigidity of the liver parenchyma according to shift-wave elastography 
and significantly lower value of endothelium-dependent vasodilatation of the brachial artery 
(p<0.05). Even a slight increase in body mass index (not higher than 34.9 kg/m2) was associated 
with a deterioration of endothelial function and structural and functional properties of heart, 
blood vessels, liver, which is more pronounced in terms of comorbidity. 
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Introduction 
    In the general structure of causes of death inUkraine, the proportion of cardiovascular mortality 
in 2014 was 66.5%. About 90% of deaths are associated with severe forms of ischemic heart 
disease and stroke, the majority of which progresses on the background of arterial hypertension. 
Arterial hypertension is one of the most common cardiovascular diseases in most European 
countries, with about 90% of its essential form being essential hypertension [Kovalenko VM, 
Karnatskyi VM, 2014]. The incidence of coronary 
heart disease and stroke in people with arterial hypertension increases 3-4 and 7 times, respectively 
[Gorbas ІM et al., 2010; Pospelov DL, 2013; Kovalenko VM, Karnatskyi VM, 2014]. 
    Along with arterial hypertension, the top threeof the most common diseases in the world are 
represente by diabetes mellitus type 2 (DM2) and obesity [American Diabetes Association, 2011; 
Kovalenko VM, Karnatskyi VM, 2014]. The WHO forecasts an increase in number of patients with 
DM2 to 380 million before 2025 [Bagry HS et al., 2008] and signs of overweight among 50% of 
the population of our planet [Cole T et al., 2000; Ametov AS, 2002; Dedov II, Melnichenko GA, 
2004]. 
   Concomitants to arterial hypertension, DM2 and obesity are associated with increased risk of 
cardiovascular events [Rabmouni K et al., 2005; Bagry HS et al., 2008; Shilov AM et al., 2009; 
Demidova TY, 2011; Syrenko YM, 2010; Colwell JA, 2011; Butrova SA, 2012]. Increased risk of 
cardiovascular events in patients with comorbid disorders, provided by a combination of arterial 
hypertension with DM2 or arterial hypertension with obesity, due to a common mechanism for the 
progression of these diseases – activation of sympathoadrenal and renin-angiotensin-
aldosteronesystems, oxidative stress, systemic inflammation, as well as hyperinsulinemia, 
hyperleptinemia, hypoadiponektinemia, and dyslipidemia [Thomas F et al., 2005; Narkiewicz K, 
2006; Guize L et al., 2007]. The implementation of these mechanisms in comorbidity leads to a 
continuously progressive remodeling of the vital organs [Kochueva MN et al., 2014]. 
Cardiac remodeling is manifested by impaired normal geometry, slow relaxation and increased 
stiffness of the myocardium, decreased myocardial contractility, which eventually leads to the 
progression of heart failure [Abel ED et al., 2008; Khurs EM, Poddubnaya AV, 2010]. Impairment 
of structural and functional state of the vascular wall is manifested by decreasing endothelium-
dependent vasodilatation of the brachial artery, increasing intima-media thickness in the carotid 
arteries and pulse wave velocity in the great vessels: the carotid artery and the abdominal aorta 
[Intengan HD, Schiffrin EL, 2001; Kochueva MN et al., 2014; Shalimova AS, 2014]. The patients 
with arterial hypertension in combination with DM2 and obesity are characterized by metabolic 
liver damageinitiated by hyperinsulinemia and insulin resistance, which lead to the increasing 
activity of enzymes that split triglycerides, fatty tissue, increase blood concentrations of free fatty 
acids and their accumulation in the cytoplasm of hepatocytes, and development of non-alcoholic 
fatty liver disease. It begins with steatosis and can transform into steatohepatitis and cirrhosis. The 
first manifestationsof non-alcoholic fatty liver disease are the manifestation of the metabolic 
syndrome at the level of the hepatic parenchyma [Bedogni G et al., 2007; Kim CH, Zobair M, 
2008; Drapkina OM et al., 2010; Tarquini R et al., 2010]. 
     Remodeling of target organs in hypertensive patients with combined pathology remains poorly 
investigated. 
The objective was to conduct a comparative study of the structural and functional state of heart, 
vessels and liver in patients with isolated essential hypertension and in terms of its combination 
with  type 2 diabetes or obesity. 
Materials and methods 
  One hundred fifty eight patients, who gave written informed consent to participate in the study 
and met the inclusion criteria, were examined at the Department of therapy and nephrology of 
Kharkiv Medical Academy of Postgraduate Education. The study groups were selected based on 
the criteria presented 
in Table 1. 
  The first group consisted of 35 essential hypertension patients with DM2 and normal body 
weight, the second consisted of 38 essential hypertension patients with DM2, overweight or I 
degree obesity. The third group consisted of 30 essential hypertension patients without DM2 
with normal body weight. The fourth group consisted of 35 essential hypertension patients 
without DM2, overweight and I degree obesity. All the groups were matched for age, sex, 
essential hypertension stage, arterial hypertension grade, and functional class of the chronic heart 
failure. The control group consisted of 20 healthy individuals, who had no signs of essential 
hypertension, DM2 and obesity after comprehensive clinical and instrumental examination. 
   Standard biochemical methods deteined glucose concentration in venous blood, glycosylated 
hemoglobin (HbA1c), and lipid profile.  
    Ultrasound examinations were performed on ULTIMA RA cardiac ultrasound scanner 
(Radmir Company, Ukraine) in one-, two-dimensional and Doppler modes with color mapping 
by conventional methods. Volumes of the left atrium and right atrium, end-systolic diameter and 
end-diastolic diameter of the left ventricle, end-diastolicpressure in the left ventricle, left 
ventricle ejection fraction, index of relative wall thickness, and myocardial mass index of left 
ventricle were measured.  
    Left ventricle diastolic function was assessed subsequent to the examination results of blood 
flow in the pulmonary artery and transmitral diastolic flow in the pulsed and tissue Doppler 
modes with the definition of the following parameters: maximum rate of early left ventricle 
filling (E), the maximum speed of late (atrial) left ventricle filling (A), the ratio of the maximum 
velocity of early and late left ventricle filling (E/A), left ventricular isovolumic relaxation time, 
deceleration time of early diastolic flow velocity, the average pulmonary artery pressure 
according to Kitabatake A. [Kitabatake A et al., 1983], the ratio of peak e and E on the mitral 
valve in spectral and tissue Doppler modes (E/e).  
     All the patients underwent endothelium-dependent vasodilatation degree assessment in 
reactive hyperemia in order to examine endothelial function. Examinations were conducted with 
5-12 MHz broadband linear transducer in Doppler color mapping 
three times on the left and right brachial artery in 15-minute intervals between samples, using the 
method of Celermajer D.S. (1994) modified by Ivanova O.V. (1998). The maximum vasodilation 
of the brachial artery normally has to exceed 10% of the original diameter. Simultaneously, we  
Table 1 
The criteria for selection of patients in research 
Inclusion criteria                                                                                     Exclusion criteria 
• age range of 45-60;                                                       • age below 45 and over 60 
• essential hypertension stage II, grade 2                        • type 1 diabetes mellitus; essential hypertension
• DM2 moderate, subcompensated 
• I–II functional class chronic heart failure 
• body mass index: 
 normal weight - 18-24.9 kg/m2 
 overweight - 25-29.9 kg/m2 
 I degree obesity - 30-34.9 kg/m2 
 abdominal obesity (IDF criteria, 2005): 
 waist circumference for men > 94 cm 
                                               for women > 80 
cm, 
• normal glomerular filtration rate 
• normal creatinine levels 
• absence of proteinuria (only 
microalbuminuria 
is admissible) 
•  established duration of: 
 essential hypertension for 8-12 years, 
 DM2 for 3-7 years, and 
 obesity for 4-5 years. 
 
 
 
stage III, grade 3 
• III-IV functional class chronic heart failure 
• DM2 in mild and severe forms in 
compensation 
and decompensation phases 
• insulin therapy in patients with type 2 diabetes 
• II-III degree obesity 
• presence of comorbidity in patients with 
essential 
hypertension and DM2: 
 acute coronary syndrome 
 myocardial infarction 
 arrhythmias and conduction 
 rheumatic heart disease 
 systemic connective tissue diseases 
 cancer diseases 
 symptomatic hypertension 
 thyroid disease, acute inflammation 
• reduced glomerular filtration rate, proteinuria 
• unsatisfactory ultrasound scan 
     • patients’ refusal from participation in the 
study 
 
measured the intima-media thickness of the carotid artery (2 cm proximal to the bifurcation of 
the common carotid artery). Pulse wave velocity by the carotid artery was determined with W-
Track- method (phase tracking method, patented by scanner manufacturers). Examination of 
pulse wave velocity in the abdominal aorta (on the left subclavian artery to the femoral artery) 
was performed using a phased transducer with a frequency of 2-4 MHz. For the shiftwave 
elastography of liver we used ULTIMA RA scanner (Radmіr Company, Ukraine) with function 
elastography and convex sensor at 1-5 MHz. The magnitude of stiffness of the liver parenchyma 
(Elast) was expressed in terms of Young’s modulus values in kilopascals (E, kPa). 
    Statistical data processing was performed using Statistics for Windows 6.0 software. The 
tables demonstrate average values and errors of average values. 
Results and discussion 
   The results of the study showed that the groups of patients are characterized by preserved left 
ventricle 
systolic function, as evidenced by the values of ejection fraction of the left ventricle in the 
normal range. Other indicators of ultrasound except left ventricle end systolic and end diastolic, 
left ventricle ejection fraction and deceleration time in patients of all the groups differed 
significantly from the control values (p<0.05) [Abel ED et аl., 2008; Kochueva MN et al., 2014].  
   The comparative analysis of the studied parameters in groups I and II (essential hypertension 
patients in combination with DM2 with normal weight and obesity) are shown in Table 2.  
  The patients with essential hypertension and DM2, whose BMI was just a bit higher (not more 
than 34.9 kg/m2), showed a significant progression in remodeling processes of blood vessels and 
liver with a significant increase in common carotid artery intima-media thickness, common 
carotid artery pulse wave velocity, Elast and a significant decrease in amount of endothelium-
dependent vasodilatation of the brachial artery (p<0.05). The negative dynamic in the values of  
 
 
 
 
 
 
Table 2
Structural and functional changes in the target  organs of patients with essential hypertension and 
diabetes mellitus type 2 
 
Index  Group I 
(n=35) 
Group II 
(n=38) 
Control group 
(n=20) 
IMT, mm *  0.88±0.01 0.96±0.01** 0.64±0.02 
PWV СА, m/s  8.15±0.12* 9.12±0.07** 5.83±0.14 
PWVAА, m/s   8.53±0.12* 9.15±0.09 6.18±0.11 
EDVD, %  6.97±0.08* 6.10±0.06** 13.01±0.20 
LV EDD, mm  4.89±0.04 5.03±0.03 4.51±0.04 
LV ESD, mm  3.20±0.03 3.32±0.02 2.84± 0.03 
EF, %  63.60±0.33 62.62±0.26 66.72± 0.75 
IRWT, U  0.48±0.01* 0.47±0.003 0.36± 0.01 
LV MMI, g/m2  141.56±2.47* 139.98±2.75 74.44± 2.34 
PAP, mm Hg  16.38±0.35* 18.40±0.34 11.47± 0.37 
Е/А, U  0.92± 0.02* 0.92± 0.02 1.15± 0.01 
DT, ms  0.17± 0.02 0.15± 0.003 0.17± 0.004 
IVRT, ms  0.13± 0.002* 0.11± 0.002 0.09± 0.002 
Е/е, U  6.08±0.14* 6.39±0.11 5.35±0.10 
Elast, kPа 10.31±0.07* 12.08±0.04** 3.20±0.05 
Notes: * – the difference between all groups and control group is reliable; ** – the difference between first and second 
groups is reliable. 
Abbreviat ions: IMT - intima media thickness, PWV - pulse wave velocity, СА – carotid artery, AA – abdominal aorta, 
EDVD - endothelium-dependent vasodilatation, LV – left ventricle, EDD - end-diastolic diameter, ESD - end-systolic 
diameter, EF – ejection fraction, IRWT - index of relative wall thickness, MMI - myocardial mass index of left ventricle, 
PAP – pulmonary artery pressure, DT - deceleration time, IVRT - index of relative wall thickness 
abdominal aorta pulse wave velocity, left ventricle end diastolic and end systolic diameters, 
pulmonary artery pressure and E/e was not significant (p>0.05). It was explained by the initial 
phase of obesity when deterioration in structure-functional state of the heart can be moderate 
[Abel ED et al., 2008; Kim CH, Zobair M, 2008; Khurs EM, Poddubnaya AV, 2010; Tarquini R 
et al., 2010].  
   The similar situation could be observed when comparing the performance of structure-
functional state of the heart, blood vessels and liver in patients from groups 3 and 4 (essential 
hypertension without DM2). A slight increase in BMI in patients with essential hypertension led 
to the deterioration in remodeling processes of the target organs, but the degree of negative 
changes was less than in patients with comorbidity. Significant differences were observed only 
in terms of endothelium-dependent vasodilatation and Elast (p<0.05). The endothelial 
dysfunction and hepatic steatosis were the most sensitive markers of organ damage in the 
presence of increasing body weight in patients with essential hypertension [Kim CH, Zobair M, 
2008; Drapkina OM et al., 2010; Tarquini R et al., 2010]. The results of the study are presented 
in Table 3. The results of index comparison in groups 1 and 3 and groups 2 and 4 demonstrated 
the contribution of DM2 to remodeling of target organs in patients with essential hypertension 
with normal and elevated body mass.  
    The results of the study indicated to a significant negative contribution of DM2 to the 
development and progression of cardiac remodeling, vascular and liver in hypertensive patients, 
regardless of body weight of patients – the value of all the main parameters studied reflected 
significantly more pronounced disorders of structural and functional state of organs in patients 
with DM2 (Table 3). 
 
Table 3
 
 
Structural and functional changes in the target organs of patients being studied 
 
Index  Group I  
(n=35) 
Group II 
(n=38) 
Group III 
(n=30) 
Group IV 
(n=35) 
Group VI 
(n=20) 
IMT, mm  0.88 ± 0.01* 0.96 ± 0.01 0.82 ± 0.02* 0.84 ± 0.01** 0.64 ± 0.02 
PWV СА, m/s  8.15 ± 0.12* 9.12 ± 0.07 7.40 ± 0.11* 7.75 ± 0.12** 5.83 ± 0.14 
PWVAА, m/s   8.53 ± 0.12* 9.15 ± 0.09 8.03 ± 0.13* 8.17 ± 0.10** 6.18 ± 0.11 
EDVD, %   6.97 ± 0.08* 6.10 ± 0.06 9.07 ± 0.17* 8.62 ± 0.15**, 
*** 
13.01 ± 0.20 
LV EDD, mm  4.89 ± 0.04 5.03 ± 0.03 4.75 ± 0.03* 4.89 ± 0.04** 4.51 ± 0.04 
LV ESD, mm  3.20 ± 0.03 3.32 ± 0.02 3.08 ± 0.02* 3.18 ± 0.03** 2.84 ± 0.03 
EF, %     63.60 ± 0.33 62.62 ± 0.26 64.46 ± 0.32 63.87 ± 0.41** 66.72 ± 0.75 
IRWT, U    0.48 ± 0.01 0.47 ± 0.003 0.47 ± 0.001 0.46 ± 0.004 0.36 ± 0.01 
LV MMI, g/m2  141.56 ± 2.47 139.98 ± 2.75 127.54 ± 2.93* 122.39 ± 2.37** 74.44 ± 2.34 
PAP, mm Hg  16.38 ± 0.35 18.40 ± 0.34 12.81 ± 0.39* 14.09 ± 0.27** 11.47 ± 0.37 
Е/А, U  0.92 ± 0.02 0.92 ± 0.02 0.87 ± 0.02* 0.90 ± 0.02 1.15 ± 0.01 
DT, ms  0.17 ± 0.02 0.15 ± 0.003* 0.26 ± 0.05 0.15 ± 0.004 0.17 ± 0.004 
IVRT, ms  0.13 ± 0.002 0.11 ± 0.002 0.11 ± 0.003 0.11 ± 0.003 0.09 ± 0.002 
Е/е, U    6.08 ± 0.14 5.67 ± 0.11* 6.39 ± 0.11 5.87 ± 0.23** 5.35 ± 0.10 
Elast, kPа  10.31±0.07 12.08±0.04 4.07±0.04* 9.74±0.08**, 
*** 
3.20±0.05 
Notes: * – the difference between first and third groups is reliable 
** – the difference between second and fourth groups is reliable 
*** – the difference between third and fourth groups is reliable 
Abbreviat ions: See table 2 for abbreviations 
 
Thus, this study made it possible to establish the negative impact of DM2 and weight gain on the 
development of structural and functional changes of the heart, blood vessels and liver in essential 
hypertension patients. 
Conclusions 
      The patients with essential hypertension stage II grade 2 without DM2 and in combination 
with subcompensated moderate DM2, showing the signs of I-II functional class chronic heart 
failure, are characterized by preserved left ventricle systolic function and deterioration of cardiac 
structural and functional state of the heart, blood vessels and liver. 
     Not depending on BMI the patients with essential hypertension and DM2 in the comparison 
with hypertensive patients had different values of thickness of the intima-media in the carotid 
arteries (which were significantly higher), different pulse wave velocities in the great vessels, the 
size of the cavities and myocardial mass of the left ventricle, the integral index of diastolic filling 
- E/e (integral ratio of maximum velocities of early diastolic filling according to spectral and 
tissue Doppler examination), the index of rigidity of the liver parenchyma according to shift-
wave elastography and significantly lower value of endothelium-dependent vasodilatation of the 
brachial artery.  
    Even a slight increase in BMI (not higher than 34.9 kg/m2) was associated with a deterioration 
of endothelial function and structural and functional properties of the heart, blood vessels, and 
liver, which is more pronounced in terms of comorbidity. 
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